Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
about
Herpes zoster in Germany: quantifying the burden of diseaseReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataThe contribution of social behaviour to the transmission of influenza A in a human population.Evaluation of a vaccination strategy by serosurveillance data: The case of varicella.The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.Modelling the transmission and control strategies of varicella among school children in Shenzhen, China.Post-herpetic neuralgia.Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary ReviewHerpes zoster surveillance using electronic databases in the Valencian Community (Spain).Active learning to understand infectious disease models and improve policy making.Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries.Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.Estimating Age-Specific Immunity and Force of Infection of Varicella Zoster Virus in Norway Using Mixture Models.Social Contact Structures and Time Use Patterns in the Manicaland Province of ZimbabweVaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMVCurrent and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccinationChildhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.Acceptance on the move: public reaction to shifting vaccination realities.The health and economic burden of chickenpox and herpes zoster in Belgium.The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.Prevention of herpes zoster pain.Varicella vaccination - the global experience.Periodicity of varicella-zoster virus in the presence of immune boosting and clinical reinfection with varicella.Modeling and predicting the long-term effects of various strategies and objectives of varicella-zoster vaccination campaigns.Fifteen years of routine childhood varicella vaccination in the United States-strong decrease in the burden of varicella disease and no negative effects on the population level thus far.Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.Evaluation of the effect of chickenpox vaccination on shingles epidemiology using agent-based modeling.Modeling the impact of changes in day-care contact patterns on the dynamics of varicella transmission in France between 1991 and 2015The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness studyAccounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models
P2860
Q21261833-A76F3391-0DDC-412F-AB80-E14F623A8C32Q26863614-A8AAE8B1-0D3C-4B0D-A8B3-99EC37CAE80DQ30364008-69005C2D-4CAE-470D-A3BD-A340B3221529Q30908568-59E71C38-D78F-4C83-A2DE-9B5B1D35A4D7Q33703581-9E6A6143-DA37-400C-A4C6-2DC2BCE825D3Q33703682-BCEAC2BA-2F71-466A-ACE2-2F34CEDC3ADCQ34460207-65A0BB46-E11A-49B8-9A08-2DAE380E14C0Q34683751-71997920-8339-415A-AB10-B31359F5F6EFQ34785366-2F486126-7605-4DFB-B754-65CA2FE2EBE2Q35008196-29F3FAC9-9EF1-415E-9283-43D8FAB0EA83Q35151816-FF25635D-EAEE-49FC-943B-C0661B695A52Q35652212-278DA25E-A9E7-42E3-BAD9-EC21BE13D2F8Q35666726-46653C8C-BE72-4E7C-B2D1-4E5F21828E34Q35886434-A474EFB4-9ED9-4566-AF57-15CF3A7FC258Q36149754-C1DD17B3-F063-4112-9FCF-FFCAEEED6854Q36252723-96CBCE44-85EF-4CD5-8AF7-AB4B8CF45D02Q36887989-BDC9F652-A2E8-49DC-86E8-4157AD8AE74CQ37135445-C2B15F8A-B1D5-4B0E-A14D-D97D39F38032Q37521887-CB0B8E70-43B0-4675-B4FA-B50AAA5F8961Q37643309-A5789824-B11E-44F7-BEA3-CDD0263306D9Q37959648-B911F4B8-5854-4B46-84C3-8632B2B3183CQ38549235-ED6EF17C-A54E-4FD3-A604-CC1CE63F152AQ38781301-7A712625-1D8C-442C-8EDF-2C706C82DB74Q39128973-7AB551CA-A37D-4943-BD0A-B76E5EF39D96Q39254009-611D1B1E-1DFC-4F6C-94E1-B04B2C880292Q39394364-FB419C1F-E1A9-4280-9582-76E5D7EA34D2Q39689778-33EBFF65-14B4-4482-A264-39464ED909BBQ40686391-D22D04DA-C063-44ED-8F34-760FD269B9BFQ41880259-0488FAE6-AE68-4812-ADD4-DCBA6F64BB51Q47556386-DEFA8166-5281-4E4A-8F4E-39E0F31D0AEDQ51047976-2ECE04CC-7279-4327-9411-20FDDE548B15Q51439781-991D543C-6045-411D-A6FB-34381B1E44EDQ55338707-C1808DE5-3F13-479F-88BE-F6973277D40AQ56776251-E29B7AF2-6103-4CFF-9A32-8CEBD6F74EBDQ57395637-71396B53-12C1-4477-9EC8-8B2AC7DA3516Q57515329-40928C8E-3450-4229-AFD4-7728BC6718C0
P2860
Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Modelling the impact of a comb ...... cella zoster virus in England.
@en
Modelling the impact of a comb ...... cella zoster virus in England.
@nl
type
label
Modelling the impact of a comb ...... cella zoster virus in England.
@en
Modelling the impact of a comb ...... cella zoster virus in England.
@nl
prefLabel
Modelling the impact of a comb ...... cella zoster virus in England.
@en
Modelling the impact of a comb ...... cella zoster virus in England.
@nl
P2093
P1433
P1476
Modelling the impact of a comb ...... icella zoster virus in England
@en
P2093
Albert Jan van Hoek
Emelio Zagheni
P304
P356
10.1016/J.VACCINE.2011.01.037
P407
P577
2011-01-28T00:00:00Z